Clinical Trial Update: Biosimilarity Study of IM Injection of Human Chorionic Gonadotrophin After Parenteral Administration of Treatment A TEST Product Epifasi 5000 I.U. Ampoules (EIPICO PHARMA, EGYPT) and Treatment B REFERENCE Product Pregnyl 5000 I.U. Ampoules (Baxter Pharmaceutical Solutions for Organon, USA). [Phase 4]

View source ↗

Summary

Phase 4 biosimilarity study comparing Epifasi 5000 I.U. hCG injections to Pregnyl 5000 I.U. with completed status in infertility (female).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility Female

Drugs mentioned

• Epifasi 5000 I.U. Ampoules (human chorionic gonadotropin)
• Pregnyl 5000 I.U. Ampoules (human chorionic gonadotropin)

Snippet

Sponsor: Genuine Research Center, Egypt | Conditions: Infertility, Female | Phase 4 | Status: COMPLETED